CREDIT SUISSE AG/ - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of TRANSPHORM INC
ValueSharesWeighting
Q4 2022$5
-99.5%
1
-99.2%
0.00%
Q3 2022$1,000125
+1150.0%
0.00%
Q2 2022$0100.00%
Other shareholders
TRANSPHORM INC shareholders Q1 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 4,619,558$10,255,4194.85%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$50,340,6761.77%
Worth Venture Partners, LLC 1,152,278$2,558,0571.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,084$555,1870.78%
Black Maple Capital Management LP 63,923$141,9090.10%
Taylor Frigon Capital Management LLC 62,500$138,7500.08%
Polar Asset Management Partners Inc. 1,009,702$2,241,5380.05%
Soros Fund Management 340,000$754,8000.01%
AMERIPRISE FINANCIAL INC 4,443,329$9,864,1910.00%
Stratos Wealth Partners, LTD. 25,640$56,9210.00%
View complete list of TRANSPHORM INC shareholders